According to the Zhitong Finance App, Haier Biotech (688139.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved operating income of 1,964 billion yuan, an increase of 11.51%; net profit to mother of 220 million yuan, an increase of 10.75%; net profit after deducting net profit of 198 million yuan, an increase of 14.26% year on year; and basic earnings per share of 0.70 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.